Sign in

CIK 0000818686 · Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
Phone
972 (3) 914-8213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-05-11 Sabag Mark See "Remarks" below Option exercise +37,884 58,482
2021-05-11 Sabag Mark See "Remarks" below Option exercise · Restricted Share Units −37,884 0
2021-05-11 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise +37,884 111,337.51
2021-05-11 Fridriksdottir Hafrun Executive VP, Global R&D Sale −19,066 $10.22 $195K 92,271.51
2021-05-11 Fridriksdottir Hafrun Executive VP, Global R&D Option exercise · Restricted Share Units −37,884 0
2021-05-11 Drape Eric Executive VP Global Operations Option exercise +37,884 92,932
2021-05-11 Drape Eric Executive VP Global Operations Sale −19,804 $10.22 $202K 73,128
2021-05-11 Drape Eric Executive VP Global Operations Option exercise · Restricted Share Units −37,884 0
2021-03-16 Sabag Mark See "Remarks" below Sale −127,244 $11.22 $1.4M 20,598
2021-03-05 Stark David Matthew Exec. VP Chief Legal Officer Grant or award · Restricted Share Units +80,798 80,798
2021-03-05 Schultz Kare President and CEO Grant or award · Restricted Share Units +285,171 285,171
2021-03-05 Sabag Mark See "Remarks" below Grant or award · Restricted Share Units +95,057 95,057
2021-03-05 O'Grady Brendan P. EVP, North America Commercial Sale −11,436 $10.54 $121K 14,868.49
2021-03-05 O'Grady Brendan P. EVP, North America Commercial Grant or award · Restricted Share Units +109,315 109,315
2021-03-05 Kalif Eliyahu Sharon EVP, Chief Financial Officer Grant or award · Restricted Share Units +85,551 85,551
2021-03-05 Fridriksdottir Hafrun Executive VP, Global R&D Grant or award · Restricted Share Units +95,057 95,057
2021-03-05 Drape Eric Executive VP Global Operations Grant or award · Restricted Share Units +90,304 90,304
2021-03-05 Dethlefs Sven EVP Global Marketing&Portfolio Grant or award · Restricted Share Units +99,809 99,809
2021-03-05 Daniell Richard Exec. VP, European Commercial Grant or award · Restricted Share Units +90,304 90,304
2021-03-04 Stark David Matthew Exec. VP Chief Legal Officer Option exercise +13,930 16,904.39

Page 46 of 76 · 1,517 trades